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Background: The impact of constant emission of hydrocarbons and contaminated water level through oil spillage in the oil and 
gas exploration and production areas of Niger Delta on women’s health cannot be underestimated. We developed a 35‑year 
standardized prediction estimates for gynecological lesions using data obtained from an integrated specialist hospital serving the 
residence of the oil and gas exploration and production City of Port Harcourt and the surrounding areas of Niger Delta, Nigeria.
Methods: The study participants comprised of 697 females who received medical care at the Braithwaite Memorial Specialist 
Hospital (BMSH), Port Harcourt, Rivers State, Nigeria, between 2010 and 2014. Predictive modeling of the diseases was 
performed using JMP statistical discovery™ software, version 12.0 (SAS Institute, Cary, NC, USA).
Results: The distribution of the gynecological lesions (n = 697) differed significantly (P < 0.001) by year of diagnosis, 
developmental stage, age category, and types of lesion. The mean age of study participants was 39.1 ± 12.8 years, and most of 
the lesions (61.8%) occurred among females who were 30‑ to 49‑year old. Leiomyoma recorded the highest 5‑year standardized 
prevalence rate of 0.508, and with no intervention, it is estimated that the number of cases diagnosed will rise from 235 in 2015 
to 1883 by the year 2050. This was followed by ovarian cyst with a prevalence rate of 0.124 and projected increase from 57 in 
2015 to 461 by the year 2050. Similarly, the product of conception is also estimated to increase from 34 to 277 by the year 2050.
Conclusion: The over 700% increased prediction of gynecological lesions by 2050 calls for urgent attention by both 
governmental and private agencies to fund awareness campaigns and screenings for women, especially for those residing 
in the oil‑ and gas‑producing areas of Niger Delta.
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Introduction
With the rapid growth in population, prediction models 
and forecasts have become more important in our 
localities.[1] Over the next 50 years, gynecological lesions 
are projected to change due to population growth, which 
is one of the largest contributors to the increasing total 
number of gynecological cases.[2,3] The world population 
as at 2015 was 7.3 billion and Nigeria population was 
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put at 183.5 million; this number is expected to increase 
to 9.7 billion and 440 million in the world and Nigeria, 
respectively, by 2050.[4-6]
The recent alarm on rising global incidence of lesions by 
the World Health Organization (WHO) should worry African 
countries, including Nigeria. Cancer killed 7.6 million persons 
in 2008 worldwide, and there is indication that the figure 
could double to 13 million by 2030.[7] Cancer accounts for 
13% of all deaths registered globally and 70% of that figure 
occurred in middle- and low-income countries.[8] It is on 
record that about 10,000 cancer deaths occurs annually in 
Nigeria,[9] whereas 250,000 new cases are recorded yearly 
with two-third of the deaths and new cancer cases recorded 
being as a result of shortage of functional cancer control 
programs in Nigeria.[9]
Since gynecological lesions frequently occur in relatively 
younger women, its toll in reducing life span is considerable. 
There have been concerns worldwide and especially in the 
developing countries because of the significant contribution 
of these conditions on morbidity and mortality.[10,11] Data on 
gynecological lesions in some developing countries show a 
preponderance of cancer of the cervix.[12,13] Cervical carcinoma 
in developing countries accounts for 80% of the estimated 
231,000 deaths that occurred from it annually.[14-17] The 
incidence and prevalence of other female genital lesions vary 
from one geographical region to another.[18] The wide global 
variation in incidence indicates that the impact of the various 
gynecological lesions would be much reduced by application 
of current knowledge of populations with high-incidence and 
death rates in any planned intervention efforts.
In the Niger Delta of Nigeria, where oil exploration and 
extraction take place, oil spills have extensively contaminated 
the landscape, polluted the soil and water with toxins, and 
are believed to have severe health effects on the inhabitants 
of the area. Although there have been series of studies to 
access the impacts on the environment,[19-21] little is known 
about the possible health effects on the people living near 
the contamination, especially women, most of who derive 
their livelihood from farming and fishing. However, there 
has been evidence in Nigeria and Kuwait that the burning 
of hydrocarbons has led to cancer, especially of the lungs.[22] 
This finding, however, remains inconclusive as the claims 
are not sufficiently supported. In other to get to the root of 
the health problems in the Niger Delta region of Nigeria, it 
is important to identify the common types of gynecological 
lesion and their prevalence rates from a major specialist 
hospital that provides comprehensive healthcare services 
to inhabitants of the metropolitan city of Port Harcourt 
and the surrounding oil-producing rural areas. Models help 
make the most of limited data in the face of the challenges. 
Although modeling has become an important ally in our 
attempts to project future occurrence of diseases and can 
have a significant impact on our distribution of resources for 
purposes of control and prevention, much of this approach 
have not been effectively exploited in Nigeria and other 
developing countries. Knowledge of this information could 
form the basis for a comprehensive research study that may 
help identify the risk factors associated with the health of 
the inhabitants of the area and lay ground work for the 
implementation of disease control and prevention measures. 
This pilot study was aimed at determining the epidemiology 
of gynecological lesions among residents of an oil city in the 
Niger Delta region, and to use the data obtained to develop 
standardized prediction estimates for the diseases in 35-year 
time (2015–2050).
The objectives of this study were to determine the prevalence 
of gynecological lesions in Braithwaite Memorial Specialist 
Hospital (BMSH), Port Harcourt, Rivers State, Nigeria, and 
to use the information obtained to develop standardized 
prediction estimates for these lesions in 35-year time 
(2015–2050).
Methods
Study area and data source
Braithwaite Memorial Specialist Hospital (BMSH) was 
established in 1925. It is a government-owned hospital, 
named after a British doctor Eldred Curwen Braithwaite. It 
is in the old Government Reserved Area (Old GRA) in Port 
Harcourt, Rivers State, Nigeria. The hospital initially served 
as a medical facility for senior civil servants, later became 
a General Hospital and presently is a major Specialist 
Health Hospital with the mandate to deliver comprehensive 
healthcare services to the metropolitan city of Port Harcourt 
and the surrounding oil-producing rural areas of Rivers State 
and the Niger Delta region of Nigeria.
Rivers State is one of the six states that make up the South-South 
geopolitical zone of Nigeria. Rivers State lies at latitude 4°45' 
north and longitude 6°50' east and covers an area of 10,432.3 
km2. As of 2010, the state had a population of 5,198,716 million 
with a density of 468 people/km2 and represented 3.7% of 
Nigeria’s total population. Port Harcourt is the capital of Rivers 
State and one of Nigeria’s leading industrial centers. The City 
lies at latitude 4°47'21'' north and longitude 6°59'55'' east, with 
a population of 1,382,592 million.
The natives of Rivers State are mainly farmers and 
fishermen, and they speak >23 main languages. The State 
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Statistical analysis
Preliminary analyses involved the descriptive statistics 
and frequency runs for the dependents and independent 
variables. Subsequently, to determine the relationships 
between the number of gynecological lesions occurring 
over the years, multiple linear regression analysis was 
conducted using the Fit Model and represented by the 
following prediction equation: Ŷ I = β0+ β1[year] I + 
β2 [Match…Lesion] i +εi, where Ŷ  is the predicted or 
expected value of the dependent (response) variable for the ith 
observation; β0 is the intercept parameter, which correspond 
to the value of the response variable when the predictor is 
0; β1 represents the change in the response variable given 
one-unit change in the predictor variable, year; β2 represents 
the change in the response variable given one-unit change in 
the second predictor variable, ith  match lesion diagnosed; and 
εi is an error term representing deviation of the line defined 
by β0 + β1[year] + β2 [Match… Lesions]. Data management, 
statistical analysis, and predictive modeling were performed 
using JMP statistical discovery™ software, version 12.0 (SAS 
Institute, Cary, NC, USA).
Ethical approval
Ethical approval was granted by the ethics committee of 
BMSH through the Hospitals Management Board of Rivers 
State, Nigeria.
Results
Characteristics of sample population
The characteristics of the sample population used 
in the current study have been presented in detail 
elsewhere.[24,25] In summary, a total of 697 gynecological 
lesions were diagnosed in the sample population with the 
majority (n = 689, 98.9%) occurring at the adults’ stage. The 
mean age of the participants studied was 39.1 ± 12.8 years 
and most of the gynecological lesions (61.8%) were 
identified among females who were aged between 30 and 
49 years. In general, the distribution of the lesions differed 
significantly (P < 0.001) by year of diagnosis, developmental 
stage, age category, and types of lesion. Gynecological 
lesions occurrence in the study population were similar 
between 2010 and 2012 and ranged from 150 (21.5%) to 
158 (22.7%). The highest prevalence was in 2013, where 
186 (26.7%) cases were reported, and the least number of 
cases were recorded in 2014 (n = 46, 6.6%).
Prediction equation model
The prediction equation model based on our study data 
with the corresponding match coefficient estimate for each 
gynecological lesion is presented on Table 1. The goodness 
of fit for the model as determined by the adjusted coefficient 
is known as the treasure base of Nigeria due to its abundant 
oil and gas resources. Oil explorations in Rivers State began 
in 1956, and since then, there has been a paradigm shift in 
the occupation and life style of the natives resulting from 
reckless environmental pollution and industrialization. 
There is very little data quantifying the oil’s impact on 
the health of people whose property, crops and livestock, 
drinking water, and air are polluted by oil, waste products 
from exploration and extraction, and extensive waste gas 
flaring.
Data collection
Six hundred and ninety-seven (n = 697) gynecological 
lesion data were obtained from the archives of 
Histopathology Laboratory of BMSH. The data represent 
the number of females who received medical care including 
histopathological evaluation at the BMSH from 2010 to 
2014 [Figure 1].
Diagnosis of gynecological lesions
The data used for this study were based on lesions identified 
through histopathology screening by qualified pathologists 
and analyzed using the methods of Onyije et al.[23] The major 
lesions identified include the following: adenocarcinoma, 
adenoma, adenomyosis, cervical polyp, chronic endometritis, 
cervical intraepithelial neoplasia, condyloma acuminatum, 
endometrial hyperplasia, endometrial polyp, leiomyoma, 
ovarian cyst, products of conception, and squamous cell 
carcinoma. Other minor lesions identified and classified 
under “others” in our study include the following: basal 
cell epithelioma, Brenner tumor, cervical cyst, chronic 
endocervicitis, chronic vulvitis, endometrial carcinoma, 
epidermal cyst, fibroma, hemangioma, ovaritis, batholin's 
cyst, vulval warts, vulvitis and yolk sac tumor (hepatoid 
variant). These lesions occurred very rarely and therefore 
were grouped for statistical convenience.
Figure 1: Distribution of number of gynecological lesions by year of diagnosis
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of determination (R2) was 0.781 with root mean square error 
of 10.529 and mean response value of 11.617.
Standardized rates and predicted estimates for 
diagnosed lesions, 2015–2050
The detailed summary of the gynecological lesions diagnosed 
among the subjects and the predicted estimates by type of 
lesions diagnosed over the 35-year period is presented in 
Table 2. The most prevalent lesion recorded over a 5-year 
period was leiomyoma (56%) with standardized mean rate 
of 0.508. This was followed by ovarian cyst, product of 
conception, and endometrial hyperplasia, which recorded 
standardized rates of 0.124, 0.075, and 0.044, respectively, 
over the 5-year period. The least diagnosed lesion was 
adenoma with standardized mean rate of 0.004. Based on 
the prevalence rates, it was estimated that incidence of 
leiomyoma among the patients’ population will increase 
from 235 in 2015 to 706 cases by the year 2025, and by the 
year 2050, an estimated 1,883 females will be diagnosed 
with the disease. Similarly, ovarian cyst, which represented 
the second most common lesion, is projected to rise from 
an average estimate of 58 in 2015 to 173 by the year 2025, 
and by year 2050, 461 women will be diagnosed with this 
lesion. Product of conception, which was ranked third in 
prevalence rates, is expected to increase from 35 diagnosed 
cases to ~104 cases by the 2025, and subsequently, increased 
to 278 by the year 2050. In general, proportional increases are 
expected over the 35-year period on all other gynecological 
lesions identified in the sample population based on the 
standardized prevalence rates.
Discussion
Gynecological lesions are public health problem, worldwide 
affecting all categories of females. It is a common cause of 
death in developed countries and among the leading causes 
of death in developing countries. Our study identified the 
top five gynecological lesions common among females 
attending BMSH in order of hierarchy as leiomyoma, 
ovarian cyst, product of conception, chronic cervicitis, and 
Table 2: Summary of prediction model: standardized and predicted estimates of gynecological lesions
Lesion Number 
of lesion
Percentage (%) Standardized* Predicted estimates (Numbers) by Year**
Mean SD Rates 2020 2025 2030 2035 2040 2045 2050
Adenocarcinoma 9 1.3 9.195 0.138 0.020 18.390 27.586 36.781 45.976 55.171 64.366 73.562
Adenoma 5 0.7 1.943 0.385 0.004 3.885 5.828 7.770 9.713 11.655 13.598 15.540
Adenomyosis 21 3.0 13.981 0.300 0.030 27.961 41.942 55.922 69.903 83.884 97.864 111.845
Cervical polyp 6 0.9 4.337 0.546 0.009 8.674 13.010 17.347 21.684 26.021 30.358 34.694
Chronic cervicitis 44 6.3 27.610 0.103 0.060 55.220 82.830 110.440 138.050 165.659 193.269 220.879
Chronic endometritis 7 1.0 6.509 0.318 0.014 13.018 19.527 26.036 32.546 39.055 45.564 52.073
CIN 9 1.3 9.880 0.280 0.021 19.760 29.640 39.520 49.400 59.280 69.160 79.040
Condyloma acuminatum 5 0.7 6.193 0.436 0.013 12.385 18.578 24.770 30.963 37.156 43.348 49.541
Endometrial hyperplasia 28 4.0 20.345 0.585 0.044 40.690 61.035 81.380 101.726 122.071 142.416 162.761
endometrial polyp 14 2.0 12.797 0.644 0.028 25.594 38.390 51.187 63.984 76.781 89.578 102.374
Leiomyoma 390 56.0 235.401 0.438 0.508 470.803 706.204 941.605 1177.007 1412.408 1647.809 1883.210
Others 20 2.9 14.112 0.151 0.030 28.224 42.336 56.448 70.560 84.672 98.784 112.896
Ovarian cyst 70 10.0 57.640 0.638 0.124 115.279 172.919 230.558 288.198 345.838 403.477 461.117
Product of conception 56 8.0 34.729 0.518 0.075 69.458 104.188 138.917 173.646 208.375 243.104 277.834
Squamous cell carcinoma 13 1.9 8.968 0.522 0.019 17.936 26.904 35.872 44.840 53.807 62.775 71.743
Total 697 100 463.639 6.003 1.000 927.277 1390.916 1854.554 2318.193 2781.832 3245.470 3709.109
SD, Standard deviation of Mean; CIN, Cervical intraepithelial neoplasia. *Standardized rates are based on prediction equation [Table 1] using observed data from 2010 to 2014 at 
maximum desirability score of 0.099296. Baseline for predicted estimates=2015. **Note that the estimates are based on standardized mean rates, and thus, represent the hospital's 
sample population (which is limited by the number of available medical charts abstracted by the researchers) and not the general population
Table 1: Prediction equation expression and coefficient 
estimates for gynecological lesions
Equation: ˆiY =2679.765 + ((‑1.327) * Year) + Match [Lesion]§




Lesion [cervical polyp] −8.687
Lesion [chronic cervicitis] −0.560
Lesion [chronic endometritis] −7.851
Lesion [CIN] −7.245
Lesion [condyloma acuminatum] −7.693
Lesion [endometrial hyperplasia] −3.024
Lesion [endometrial polyp] −6.524
Lesion [leiomyoma] 68.640
Lesion [others] −5.024
Lesion [ovarian cyst] 4.640
Lesion [product of conception] 1.840
Lesion [squamous cell carcinoma] −6.774
CIN, Cervical intraepithelial neoplasia Model information: R‑square=0.8370; adjusted 
R‑square=0.781; root mean square error=10.529, mean of response=11.617. 
§Predicted estimates can be determined by substituting year and the match coefficient 
estimate of gynecological lesion of interest
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endometrial hyperplasia. These lesions are predicted to 
increase in the population to the range of 797%–815% in 
35-year time. There has been little or no information on the 
prediction estimates of gynecological lesions in Nigerian 
tertiary hospitals. Therefore, our study is the first attempt 
at filling this knowledge gap, and we are hopeful that the 
data obtained will provide the needed basic information 
to engender interest among researchers and governmental 
agencies in addressing this important public health problem.
WHO reported that about 24.6 million people live with cancer 
worldwide.[26] Parkin et al.[8] reported that in indigenous 
Africans, 650,000 people of the estimated 965 million were 
diagnosed of cancer annually, and a lifetime risk of dying 
from cancer in African women was reported to be two times 
higher than in developed countries.[27] In the United States, 
it was reported that leiomyoma-related hospitalized cases 
will rise from 37,134 in 2010 to 49,154 in 2050 with an 
increase of 22% in black women and 8% in white women.[28] 
This is inconceivably lower when compared with the 801% 
increase (235–1,883 by 2050) reported in our current study 
for leiomyoma lesion, although the present research focused 
on one tertiary hospital.
Studies have shown that high incidence of leiomyoma occurs 
within the age of 35 years[27,28] and early menarche has also 
been identified as a factor.[29,30-32] According to Baird and 
Dunson,[33] Parazzini,[34] and Wise et al.,[35] parity and pregnancy 
are contributory factors to the rise in cases of leiomyoma. 
Other factors include caffeine intake[36] and estrogen.[37] 
Estrogen influences the growth of leiomyoma and decreased 
estrogen regresses its growth.[37] Flake et al.[38] reported high 
concentrations of estrogen receptor (at 6q25.1 and 14q) in 
leiomyomata than in other lesions.[37] Estrogen dominance 
is a complex situation caused by excess exposure to 
environmental xenoestrogens (made up of hydrocarbons), 
which may arise from oil and gas exploration.[37] Ngokere 
et al.[39] has earlier reported increased estradiol and decreased 
progesterone in rabbits administered with Escravos crude 
oil. The use of synthetic estrogens, such as the birth control 
pill and hormone replacement therapy, anovulation which 
is common among women older than 35 years; unresolved 
emotional issues; poor diet; and negative lifestyle factors, 
such as smoking and alcohol, are also contributing factors.[40]
Similarly, ovarian cyst which were predicted in this study 
to increase from 58 to 461 by 2050 is higher than the 
projection for Ireland as a country, where it was reported that 
ovarian cyst will increase from 407 cases in 2015 to 662 by 
2040.[41] Retained products of conception, which is the third 
highest predicted lesion in our study are associated with 
complication from labor and delivery. The retained tissue can 
cause prolonged postpartum hemorrhage and endometritis. 
The usual treatment is curettage, which results in further 
complications in 7% of patients, including uterine perforation, 
cervical laceration, and subsequent synechia formation.[42] 
Retained products of conception are suspected when routine 
examination of the placenta at delivery reveals an incomplete 
placenta or when a patient has signs of endometritis or 
prolonged vaginal bleeding in the postpartum period.[43]
Studies have shown that relationship exists between people 
living in close proximity to oil- and gas-contaminated areas 
and pregnancy complications, partly due to polluted sources 
of water by chemicals from the exploration and production 
of oil and gas.[44,45] Hurtig and Sebastian[44] reported in their 
study in Ecuador that miscarriages were found to be much 
more prominent in oil-contaminated areas with a risk of 
2.34 times higher spontaneous abortion in communities 
situated near oil-contaminated environments. More than 60% 
of communities in Rivers State suffer the same fate as the case 
reported in Ecuador. Umunnakwe[46] reported hydrocarbon 
leakages into grand water wells of two oil-producing 
communities (Obite and Egita) in Ogba, Rivers State, Nigeria. 
Similar report of extensive oil contamination of rivers, creeks, 
and ground water in Ogoni land in Rivers State was also 
given by Olof and Jonas.[47] These reports tend to highlight 
the possible link of oil-contaminated environments with the 
prevalence of these lesions identified in our study. However, 
further research is needed to uncover the existence of such 
a relationship.
Study limitations
There are some limitations in our current study that may 
highlight opportunities for future method enhancement. 
The study was based on data collected from only one tertiary 
hospital, and thus, may not be representative of the actual 
prevalence of the various gynecological lesions in the general 
population. Also, several independent factors of interest 
including participants’ occupation and race/ethnicity were not 
captured in the original data making it impossible to associate 
these factors with the distribution and predictive patterns. 
Consequently, while the predictive estimates obtained are 
the first of its kind in Nigeria, it is important to interpret the 
predicted prevalence rates of the diseases with caution as any 
effective intervention and control program may significantly 
alter these estimates in future.
Conclusion
Leiomyoma, ovarian cyst, and product of conception are 
the most prevalent gynecological lesions among patients 
receiving medical care at the BMSH and they have been 
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predicted to increase alongside other lesions in the next 
35 years. However, application of effective intervention 
and control measures such as alteration of life style (sexual 
behavior), vaccination against human papillomavirus (HPV), 
cytological screening, early clinical detection, and treatment 
and improved therapy could help reduce incidence and 
mortality rates associated with these diseases. In addition, 
healthcare physicians specializing in cancer care for women 
need to be alert to every opportunity to improve cancer 
screening and prevention among the growing and aging 
female populations in Nigeria, and other less-developed 
countries. More researches are needed to uncover the impact 
of oil and gas exploration, extraction, and environmental 
pollution on health outcomes in the oil-producing areas of 
Nigeria, and elsewhere around the world.
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